ArticleImmunobiology2021

Antigenic sites in SARS-CoV-2 spike RBD show molecular similarity with pathogenic antigenic determinants and harbors peptides for vaccine development.

Tikam Chand DakalPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.